Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Laparoscopic radical cystectomy for bladder cancer with prostatic and neurovascular sparing: initial experience.
Gou X, Wang M, He WY, Liu CD, Deng YZ, Ren K, Chen Y.
Int Urol Nephrol. 2012 Jun;44(3):787-92. Epub 2012 Jan 17.
Related citations
Urothelial cancers after renal transplantation.
Cox J, Colli JL.
Int Urol Nephrol. 2011 Sep;43(3):681-6. Epub 2011 Mar 4.
Extraperitoneal radical cystectomy and ureterocutaneostomy in octogenarians.
De Nunzio C, Cicione A, Leonardo F, Rondoni M, Franco G, Cantiani A, Tubaro A, Leonardo C.
Int Urol Nephrol. 2011 Sep;43(3):663-7. Epub 2010 Nov 26.
Assessment of long-term quality of life in patients with orthotopic neobladder followed for more than 5 years.
Takenaka A, Hara I, Soga H, Sakai I, Terakawa T, Muramaki M, Miyake H, Tanaka K, Fujisawa M.
Int Urol Nephrol. 2011 Sep;43(3):749-54. Epub 2010 Oct 30.
Narrow-band imaging flexible cystoscopy in the detection of primary non-muscle invasive bladder cancer: a "second look" matters?
Shen YJ, Zhu YP, Ye DW, Yao XD, Zhang SL, Dai B, Zhang HL, Zhu Y.
Int Urol Nephrol. 2012 Apr;44(2):451-7. Epub 2011 Jul 27.
Population densities in relation to bladder cancer mortality rates in America from 1950 to 1994.
Colli J, Lee BR, Thomas R.
Int Urol Nephrol. 2012 Apr;44(2):443-9. Epub 2011 Jun 24.
Current chemotherapeutic strategies against bladder cancer.
Mitsui Y, Yasumoto H, Arichi N, Honda S, Shiina H, Igawa M.
Int Urol Nephrol. 2012 Apr;44(2):431-41. Epub 2011 Jun 12.
Pigment epithelium-derived factor expression is down-regulated in bladder tumors and correlates with vascular endothelial growth factor and matrix metalloproteinase-9.
Feng CC, Ding Q, Zhang YF, Jiang HW, Wen H, Wang PH, Wu Z.
Int Urol Nephrol. 2011 Jun;43(2):383-90. Epub 2010 Sep 17.
Prediction of prognosis after radical cystectomy for pathologic node-negative bladder cancer.
Park E, Ha HK, Chung MK.
Int Urol Nephrol. 2011 Dec;43(4):1059-65. Epub 2011 May 28.
T1G3 high-risk NMIBC (non-muscle invasive bladder cancer): conservative treatment versus immediate cystectomy.
De Berardinis E, Busetto GM, Antonini G, Giovannone R, Gentile V.
Int Urol Nephrol. 2011 Dec;43(4):1047-57. Epub 2011 Mar 29.
Bladder cancer after managing upper urinary tract transitional cell carcinoma: risk factors and survival.
Milojevic B, Djokic M, Sipetic-Grujicic S, Milenkovic-Petronic D, Vuksanovic A, Dragicevic D, Bumbasirevic U, Tulic C.
Int Urol Nephrol. 2011 Sep;43(3):729-35. Epub 2011 Feb 26.
Does intubated uretero-ureterocutaneostomy provide better health-related quality of life than orthotopic neobladder in patients after radical cystectomy for invasive bladder cancer?
Vakalopoulos I, Dimitriadis G, Anastasiadis A, Gkotsos G, Radopoulos D.
Int Urol Nephrol. 2011 Sep;43(3):743-8. Epub 2011 Feb 20.
Long-term outcomes of radical cystectomy with preservation of prostatic capsule.
Dall'Oglio MF, Antunes AA, Crippa A, Nesrallah AJ, Srougi M.
Int Urol Nephrol. 2010 Dec;42(4):951-7. Epub 2010 May 20.
Additive antitumoral effect of interleukin-12 gene therapy and chemotherapy in the treatment of urothelial bladder cancer in vitro and in vivo.
Liu W, Cao Y, Fernández MI, Niu H, Xiu Y.
Int Urol Nephrol. 2011 Sep;43(3):721-7. Epub 2010 Nov 12.
Using urine microscopy and cytology for early detection of bladder cancer in male patients with lower urinary tract symptoms.
Chan ES, Ng CF, Hou SM, Yip SK.
Int Urol Nephrol. 2011 Jun;43(2):289-94. Epub 2010 Nov 4.
The practice of the first check cystoscopy following radiotherapy for the treatment of muscle-invasive (T3N0M0) bladder cancer: a UK national survey.
Mohammed A, Hameed A, Shergill I, Barua J.
Int Urol Nephrol. 2011 Jun;43(2):377-81. Epub 2010 Jun 20.
The role of adjuvant chemotherapy in patients with locally advanced (pT3, pT4a) and/or lymph node-positive bladder cancer.
Reşorlu B, Türkölmez K, Ergün G, Baltacı S, Göğüş C, Bedük Y.
Int Urol Nephrol. 2010 Dec;42(4):959-64. Epub 2010 Apr 20.
Evaluation of relationship between HIF-1alpha immunoreactivity and stage, grade, angiogenic profile and proliferative index in bladder urothelial carcinomas.
Deniz H, Karakök M, Yagci F, Güldür ME.
Int Urol Nephrol. 2010 Mar;42(1):103-7. Epub 2009 May 30.
Up-regulation of microRNA in bladder tumor tissue is not common.
Wang G, Zhang H, He H, Tong W, Wang B, Liao G, Chen Z, Du C.
Int Urol Nephrol. 2010 Mar;42(1):95-102. Epub 2009 May 28.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on